z-logo
Premium
α 2A ‐Adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice
Author(s) -
Fagerholm V,
Scheinin M,
Haaparanta M
Publication year - 2008
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/bjp.2008.186
Subject(s) - phentolamine , glibenclamide , endocrinology , medicine , insulin , imidazoline receptor , chemistry , diabetes mellitus , receptor
Background and purpose: The imidazoline‐type α 2 ‐adrenoceptor antagonists (±)‐efaroxan and phentolamine increase insulin secretion and reduce blood glucose levels. It is not known whether they act by antagonizing pancreatic β‐cell α 2 ‐adrenoceptors or by α 2 ‐adrenoceptor‐independent mechanisms. Many imidazolines inhibit the pancreatic β‐cell K ATP channel, which is the molecular target of sulphonylurea drugs used in the treatment of type II diabetes. To investigate the mechanisms of action of (±)‐efaroxan and phentolamine, α 2A ‐adrenoceptor knockout (α 2A ‐KO) mice were used. Experimental approach: Effects of (±)‐efaroxan, 5 mg kg −1 , and phentolamine, 1 mg kg −1 , on blood glucose and insulin levels were compared with those of the non‐imidazoline α 2 ‐adrenoceptor antagonist [8a R ,12a S ,13a S ]‐5,8,8a,9,10,11,12,12a,13,13a‐decahydro‐3‐methoxy‐
12‐(ethylsulphonyl)‐6 H ‐isoquino[2,1‐g][1,6]naphthyridine (RS79948‐197), 1 mg kg −1 , and the sulphonylurea glibenclamide, in α 2A ‐KO and control (wild type (WT)) mice. Key results: In fed WT mice, (±)‐efaroxan, phentolamine and RS79948‐197 reduced blood glucose and increased insulin levels. Fasting abolished these effects. In fed α 2A ‐KO mice, (±)‐efaroxan, phentolamine and RS79948‐197 did not alter blood glucose or insulin levels, and in fasted α 2A ‐KO mice, blood glucose levels were increased. Glibenclamide, at a dose only moderately efficacious in WT mice (5 mg kg −1 ), caused severe hyperinsulinaemia and hypoglycaemia in α 2A ‐KO mice. This was mimicked in WT mice by co‐administration of RS79948‐197 with glibenclamide. Conclusions and implications: These results suggest that (±)‐efaroxan and phentolamine increase insulin secretion by inhibition of β‐cell α 2A ‐adrenoceptors, and demonstrate a critical role for α 2A ‐adrenoceptors in limiting sulphonylurea‐induced hyperinsulinaemia and hypoglycaemia. British Journal of Pharmacology (2008) 154 , 1287–1296; doi: 10.1038/bjp.2008.186 ; published online 19 May 2008

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom